Is This Big Pharma Giant Headed for Another Breakup?
Generic drugmakers Actavis, Valeant, and Mylan are all reportedly interested in Pfizer's generic drug business. Will Pfizer play ball and sell off yet another one of its slower-growth units?
Keep An Eye on Pfizer Inc., GW Pharmaceuticals PLC - ADR, and VIVUS Inc. Today
Pfizer, GW Pharmaceuticals, and VIVUS could make health care headlines this morning. Here’s why.